These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24342716)

  • 21. Barth Syndrome Cardiomyopathy: An Update.
    Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
    Ikon N; Ryan RO
    Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues.
    Lu B; Kelher MR; Lee DP; Lewin TM; Coleman RA; Choy PC; Hatch GM
    Biochem Cell Biol; 2004 Oct; 82(5):569-76. PubMed ID: 15499385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain.
    Hijikata A; Yura K; Ohara O; Go M
    Meta Gene; 2015 Jun; 4():92-106. PubMed ID: 25941633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-
    Suzuki-Hatano S; Sriramvenugopal M; Ramanathan M; Soustek M; Byrne BJ; Cade WT; Kang PB; Pacak CA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Exonic Splicing Mutation in the TAZ (G4.5) Gene in a Case with Atypical Barth Syndrome.
    Fan Y; Steller J; Gonzalez IL; Kulik W; Fox M; Chang R; Westerfield BA; Batra AS; Wang RY; Gallant NM; Pena LS; Wang H; Huang T; Bhuta S; Penny DJ; McCabe ER; Kimonis VE
    JIMD Rep; 2013; 11():99-106. PubMed ID: 23606313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BARTH SYNDROME IN MALE AND FEMALE SIBLINGS CAUSED BY A NOVEL MUTATION IN THE TAZ GENE.
    Avdjieva-Tzavella DM; Todorova AP; Kathom H M ; Ivanova MB; Yordanova IT; Todorov TP; Litvinenko IO; Dasheva-Dimitrova AT; Tincheva RS
    Genet Couns; 2016; 27(4):495-501. PubMed ID: 30226969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barth syndrome.
    Clarke SL; Bowron A; Gonzalez IL; Groves SJ; Newbury-Ecob R; Clayton N; Martin RP; Tsai-Goodman B; Garratt V; Ashworth M; Bowen VM; McCurdy KR; Damin MK; Spencer CT; Toth MJ; Kelley RI; Steward CG
    Orphanet J Rare Dis; 2013 Feb; 8():23. PubMed ID: 23398819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven functional classes of Barth syndrome mutation.
    Whited K; Baile MG; Currier P; Claypool SM
    Hum Mol Genet; 2013 Feb; 22(3):483-92. PubMed ID: 23100323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Drosophila model of Barth syndrome.
    Xu Y; Condell M; Plesken H; Edelman-Novemsky I; Ma J; Ren M; Schlame M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11584-8. PubMed ID: 16855048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
    Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG
    J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of TAZ mutations in pediatric patients with cardiomyopathy by targeted next-generation sequencing in a Chinese cohort.
    Wang J; Guo Y; Huang M; Zhang Z; Zhu J; Liu T; Shi L; Li F; Huang H; Fu L
    Orphanet J Rare Dis; 2017 Feb; 12(1):26. PubMed ID: 28183324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.
    Suzuki-Hatano S; Saha M; Rizzo SA; Witko RL; Gosiker BJ; Ramanathan M; Soustek MS; Jones MD; Kang PB; Byrne BJ; Cade WT; Pacak CA
    Hum Gene Ther; 2019 Feb; 30(2):139-154. PubMed ID: 30070157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.
    Garlid AO; Schaffer CT; Kim J; Bhatt H; Guevara-Gonzalez V; Ping P
    Gene; 2020 Feb; 726():144148. PubMed ID: 31647997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.